Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
trinko schreef op 28 september 2016 10:55 :
Bij een winst van 30pence of meer ben ik voorzichtig den ik een koers van 6 voor de jaarcijfers. En dan nog vooruit kijken nar volgend jaar bij verdere winst groei is een
keenkoers van tussen de 800 en 1000 mogelijk
Trinko
hoi Trinko, mocht die koers er echt een keer komen, 8 tot 10 pond, dan neem ik afscheid van soof. want zoveel geld laat ik niet lopen, heb 10.000 aandeeltjes daar heb ik 17.800 euro voor betaalt. ben er blij mee, zit nu aan een flinke winst, was van plan ze vast te houden tot eind cijfers 2019. benieuwt wat de koers tot die tijd gaat doen, denk dat mence ook onderhand in die tijd afscheid neemt van soof. gr sproet,
Super Marbles! Klinkt zeer rust en hoop gevend , bedankt voor het plaatsen!!!! Trinko
Top gevonden marbles!! En paar steekwoorden waren: safe, kans op een grote doorbraak, en de man had zelf ook positie ingenomen, wat we zo vaak dachten werd vandaag verteld, mooie stukje promotie!
Gartje en hij zou er nog wat bij kopen zei hij:-)))
[quote alias=marblesthegame id=9607187 date=201609281834]audioboom.com/boos/5102932-three-uk-s... Vanaf minuut 3:33 [/quote marbles, mooi werk van je, hoe je dit gevonden hebt. sproet.
Gartje schreef op 28 september 2016 19:24 :
Top gevonden marbles!! En paar steekwoorden waren: safe, kans op een grote doorbraak, en de man had zelf ook positie ingenomen, wat we zo vaak dachten werd vandaag verteld, mooie stukje promotie!
Safe, maar hij zei ook dat het speculatief was, aan de veilige kant. Maar het volgende bedrijf, Hasting, benoemde hij dan wel weer als "much safer". Dus dat is maar relatief. Ik weet niet hoeveel mensen hier naar luisteren. Als dit van gisteren is, dan heeft het weinig impact gehad.............. Klaas
For immediate release SOPHEON PLC ("Sopheon" or the "Company") Issue of Equity Sopheon, the international provider of software, expertise, and best practices for Enterprise Innovation Management, announces today that it has issued and allotted 17,000 ordinary shares of 20 pence each in the capital of the Company ("Ordinary Shares") in connection with the exercise of share options by an employee. Application has been made for the total of 17,000 new Ordinary Shares to be admitted to trading on AIM, and dealings are expected to commence on 5 October 2016. The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares. The total number of Ordinary Shares in issue following Admission will be 7,319,696. The Company does not hold any shares in treasury. Accordingly, the figure of 7,319,696 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules. Trinko
Vraagje klopt dit dan zou sopheon op 3november met een tranig-update komen ik hoop het en ben er benieuwd na!!! Evénements à venir sur SOPHEON 03/11/16 Q3 2016 Publication de résultats (estimation) 23/03/17 Année 2016 Publication de résultats (estimation) 11/05/17 Q1 2017 Publication de résultats (estimation) Trinko
Roadmapping for Agile Business Strategy with Dr. Robert Phaalwww.sopheon.com/roadmapping-for-agile...
Market Guide for Strategy Execution Software Published: 21 September 2016 ID: G00292527 Analyst(s): Donna Fitzgerald, Teresa Joneswww.gartner.com/doc/reprints?id=1-3JD...
Synergy International Systems heef een kw van bijna 38 bij een winst van 1,57$ per aandeel. Mocht sopheon zo een ),0,50$ winst per aandeel gaan maken(wat mogelijk is dit jaar )zou een koers van 19$ mogelijk moeten zijn en dan nog niet naar verdere groei gekeken. 19 :1,25=zou 15 pond zijn! laat me even dromen. Maar mochten ze echt zo door blijven groeien moet een koers van om de nabij 10 pond volgend jaar toch echt mogelijk zijn. Nogmaals bedankt voor het plaatsen van voorafgaand bericht! Mvg Trinko
theophiel,ik heb je net een ABtje geven:) gr sproet.
www.sopheon.com/how-parker-hannifin-i... Sopheon customer Parker Hannifin® has deep roots in innovation. Back in the 1930s, Parker Appliance (now Parker Hannifin) launched copper tubing for hydraulic installation to market before anyone else, and was also the first to use tubing for the instrumentation of power plants.1 Fast forward to October 2014 when Parker proudly opened the doors at its Donald E. Washkewicz Polymer Innovation Center, and Parker's Corporate Vice President of Technology and Innovation, Craig Maxwell, saw the realization of his dream for a dedicated space for R&D and pet projects.2 And in 2016, the Sporlan Division of Parker Hannifin was awarded two Innovation Awards at the AHR Expo in the "Cooling" and "Tools & Instruments" categories.3 enz.
We zien er nog niets van in de koers theo, maar komt goed allemaal!
Gartje schreef op 25 oktober 2016 15:46 :
We zien er nog niets van in de koers theo, maar komt goed allemaal!
De koers zwabbert wat naar beneden en dan weer naar boven, maar uiteindelijk gaan we er toch wel komen, naar mijn mening. Hopelijk laat men toch nog wat horen vanuit Sopheon dit jaar. Groet.
www.branduk.net/sopheon-spe-still-und... En kijk eens naar de prijs, o.a. helemaal onderaan Sopheon (SPE) – Still undervalued says VectorVest due to forecasted earnings growth UK based Sopheon plc (SPE) is engaged in the provision of software and services in the product lifecycle management (PLM) market. The Company operates in two segments: North America and Europe. It’s Accolade solution consists of various modules, including Portfolio Management, which enable companies to prioritize product ideas, focus on resources, and bring the right products to market on time; Idea Development that develops new product ideas; Resource Planning, which aligns resources with new product development opportunities; document routing software; and Microsoft Integration that ensures process adoption and adherence. The company also offers Vision Strategist, a strategic product planning solution designed for product and IT road mapping; Accolade for Clinical Trials, which structures and automates the clinical trial process; Accolade healthcare protocol management software; and Evidence Monitor solution, which monitors targeted medical journals and databases, filters and analyzes their content, and provides alerts on information and developments related to the user’s areas of specialization. In addition, it provides consultancy and implementation services, such as requirements definition, configuration, installation, and post-production support. It principally serves automotive, aerospace, and defense sectors.Its subsidiaries include Sopheon Corporation, Alignent Software, Inc., Sopheon NV, Sopheon UK Ltd and Sopheon GmbH. On 25th August 2016, Sopheon published interim results to the end of June, revealing a pre-tax profit of $1.6m compared to a $0.5m loss previously, on revenues up to $11.5m from $8.4m. EBITDA improved to $2.9m ($0.9m). Sopheon said 20 license transactions were closed in the period from new and existing customers compared to 15 in 2015. This included “a very substantial” order from an existing enterprise tier customer, meaning that although license deal volume increased by a third, license revenues doubled. Additionally, services revenues increased by over 50%. Looking forward, Sopheon said revenue visibility for the full-year 2016 now stands at $18.4m from just under $17m at the time of the annual general meeting in June and $15m in the previous year. Chairman Barry Mence said: “We believe that Sopheon is well positioned to capitalise on the opportunities and deliver continued progress.” The growth potential at Sopheon had been picked up by the VectorVest stock screening system at the start of the year, when the stock traded at around 70p. Among a range of metrics highlighting value, the stock was flagged on the VectorVest Growth to P/E Ratio (GPE), which compares earnings growth rate to P/E ratio. It was noted that Sopheon has a GPE rating of 3.69. With long-term interest rates currently at 3.79%, the operative GPE ratio is 0.14, meaning Sopheon is considered to be undervalued. Secondly the Earnings Growth Rate (GRT), (which reflects a company’s one to three year forecasted earnings growth rate in percent per year) sees Sopheon score very highly with a GRT of 38%. Finally, despite the recent rise in the stock price, the VectorVest Value metric attributes a current value of 525.06p per share to Sopheon, meaning the company is still undervalued at the current 286.00p per share. The chart of Sopheon is shown. The green line above the price chart is the VectorVest calculated valuation while the blue line in the window below the price is Earnings per Share (EPS). Technically the share is charting a symmetrical triangle with the price currently at support within the triangle. If the triangle breaks to the upside (and the fundamentals strongly think it should) then the target can be calculated by measuring the height of the move prior to the consolidation. This is known as a measured move by chartists and it suggests that a move of 200p is probable. This would take the share price to the current valuation of 525p. Traders can buy at support within the triangle or wait for a breakout of the trendline defining resistance within the triangle. VectorVest automatically calculates a stop loss and at the moment this should be placed at around 260p. To summarise, the rate at which Sopheon continues to grow earnings marks this company out as a quality play. VectorVest attributes a current value of 525.06p per share to the stock, meaning the company is still undervalued at the current 286.00p per share. Buy. David Paul
veel orders komen pas een dag later op de beurs in londen, werkt wel verwarrend wat de werkelijke koers is.
Theophiel was al eerder bekend kijk draadje oktober
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Indices
AEX
874,02
-0,09%
EUR/USD
1,0699
-0,03%
FTSE 100
8.040,38
-0,06%
Germany40^
18.086,70
-0,01%
Gold spot
2.316,89
+0,03%
NY-Nasdaq Composite
15.712,75
+0,10%
Stijgers
Dalers